HiFiBiO Therapeutics

Hi Fi Bi O Therapeutics

Biotechnology, 237 Putnam Ave, Cambridge, Massachusetts, 02139, United States, 51-200 Employees

hifibio.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +16*********

Who is HIFIBIO THERAPEUTICS

HiFiBiO Therapeutics is a clinical-stage global biotech pioneering a unique high-resolution translational solution (DIS, Drug Intelligence Science) to enhance the probability of success f...

Read More

map

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from HIFIBIO THERAPEUTICS

HiFiBiO Therapeutics Org Chart and Mapping

Liang Schweizer

Founder, Chairperson and CEO

Employees

Monika M

Senior Associate Scientist, Clinical Data Science

Xi Lin

Associate Scientist - Translational Science

Gabrielle Wong

Associate Director - Head of Precision Medicine

Liwen Y

Associate Director, Human Resources

Olja Rapaic

Clinical Trial Manager

Roshan Kumar

Senior Director, Head of Exploratory Biology and External Innovation

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding HiFiBiO Therapeutics

Answer: HiFiBiO Therapeutics's headquarters are located at 237 Putnam Ave, Cambridge, Massachusetts, 02139, United States

Answer: HiFiBiO Therapeutics's phone number is +16*********

Answer: HiFiBiO Therapeutics's official website is https://hifibio.com

Answer: HiFiBiO Therapeutics's revenue is $10 Million to $25 Million

Answer: HiFiBiO Therapeutics's SIC: 2834

Answer: HiFiBiO Therapeutics's NAICS: 325412

Answer: HiFiBiO Therapeutics has 51-200 employees

Answer: HiFiBiO Therapeutics is in Biotechnology

Answer: HiFiBiO Therapeutics contact info: Phone number: +16********* Website: https://hifibio.com

Answer: HiFiBiO Therapeutics is a clinical-stage global biotech pioneering a unique high-resolution translational solution (DIS, Drug Intelligence Science) to enhance the probability of success for immunotherapies. DIS combines unique single-cell capabilities with AI/ML approaches using patient samples to discover novel targets, effective antibody drugs, and predictive biomarkers. With DIS, HiFiBiO gains an unprecedented understanding of immune modulation in human diseases driving a robust clinical pipeline of transformative immunotherapies. Additionally, HiFiBiO has partnered with major multinational pharmaceutical and biotech companies applying its innovative DIS approach. HiFiBiO Therapeutics is headquartered in Cambridge, MA with additional operations in Paris, France, Hong Kong, Shanghai, and Hangzhou, China.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access